• SENSEX 72,529.07
    -242.65 (--0.33%)
  • BANKNIFTY 54,259.95
    -211.70 (--0.39%)
  • Cube Highways
    156.41 162.00(%)
  • NSE
    1,793.70 1,878.00(%)
  • 360 ONE
    1,019.75 906.20(%)
  • SS Retail
    775.00 888.00(%)
  • Cupid
    292.35 298.95(%)
  • R Systems Intl.
    305.25 446.55(%)
  • GE Vernova T&D
    4,225.00 5,650.00(%)
  • Lords Mark Industries
    84.89 60.00(%)
  • PB Fintech.
    1,076.35 1,076.35(%)
  • Azad Engineering
    2,997.65 2,997.65(%)
  • Hero Motors
    140.75 156.03(%)
  • HDFC Bank
    720.00 1,020.35(%)
  • Reliance Industries
    1,182.05 1,182.05(%)
  • Delhivery
    418.15 524.25(%)
  • Ather Energy
    1,404.00 542.20(%)
  • Varmora Granito
    163.45 163.45(%)
  • Bharti Airtel
    1,788.00 2,174.70(%)
  • Indian Hotels Co
    725.50 757.10(%)
  • ICICI Lombard
    1,498.00 1,423.95(%)
  • Bajaj Finance
    961.65 788.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Kilitch Drugs (India) Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3630.0
  • ISIN : INE729D01010
216.76 0 (-0.13%)
  • As on 29 Sep 2026 (EOD)

  • Today’s Low

    216.00

  • Today’s High

    224.00

  • Open

    224.00

  • Perv Close

    217.05

  • 52W Low

    117.25

  • 52W High

    232.50

Key Indicators

  • P/E(TTM)

    23.61

  • Mar.Cap (₹Cr.)

    757.83

  • Div & Yield %

    0.00

  • Book Value(₹)

    95.25

  • Debt-Equity Ratio

    -0.13

  • AGM Date

    29-Sep-2026

  • EPS

    9.34

  • P/E Ratio

    23.61

Financials Ratios

  • Debt-Equity Ratio

    0.16

  • Mar.Cap (₹Cr.)

    757.83

  • RONW (%)

    8.28

  • ROCE (%)

    13.30

Score Board

  • Equity (₹ in Cr.)

    34.96

  • BV (₹)

    95.20

  • Sales( ₹ in Cr.)

    188.57

  • NP (in Cr.)

    27.81

  • NP Var(%)

    21.0

  • Div%

    0.0

  • CPS (₹)

    8.60

  • EPS (₹)

    8.00

  • Traded Value (₹ in Lakhs)

    770.90

  • 52 Week High

    232.50

  • 52 Week Low

    117.25

  • Price BSE

    221.0

  • Price NSE

    217.00

  • Market Capital( in Cr.)

    770.90

  • P/C Ratio

    25.70

  • P/E Ratio

    27.80

  • Price Vs.BV

    8.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 188.57 181.59 131.60 117.78 105.16 70.02
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 188.57 181.59 131.60 117.78 105.16 70.02
Other Income 13.85 13.72 6.19 4.60 4.56 4.19
Stock Adjustments -1.07 1.17 0.12 -0.23 0.05 -1.09
Total Income 201.35 196.48 137.91 122.15 109.77 73.12
EXPENDITURE :            
Raw Materials 87.80 93.19 66.33 58.27 60.29 37.97
Power and Fuel Cost 2.61 2.61 2.36 2.15 2.00 1.57
Employee Cost 12.34 10.03 7.91 7.47 6.15 5.22
Other Manufacturing Expenses 6.95 5.52 4.69 5.37 5.91 5.48
Selling and Administration Expenses 39.37 38.03 26.70 23.08 16.48 11.11
Miscellaneous Expenses 5.27 2.25 3.29 3.88 3.25 2.25
Employee Benefit Expenses 12.34 10.03 7.91 7.47 6.15 5.22
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 154.33 151.64 111.29 100.22 94.08 63.59
Operating Profit 47.02 44.83 26.62 21.94 15.69 9.53
Interest 3.18 2.40 2.02 1.15 0.80 0.88
Gross Profit 43.84 42.43 24.60 20.79 14.89 8.65
Depreciation 2.29 1.74 1.24 1.34 0.96 1.14
Profit Before Tax 41.55 40.69 23.36 19.45 13.93 7.51
Current Tax 10.86 9.85 6.37 4.20 3.63 1.67
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -1.70 -0.32 -0.59 -0.47 -0.23 -0.31
Reported Net Profit 32.40 31.16 17.57 15.72 10.53 6.16
Extraordinary Items 4.59 8.10 1.01 0.77 1.00 0.94
Adjusted Net Profit 27.81 23.06 16.56 14.95 9.53 5.22
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 162.69 131.53 113.96 98.24 87.71 81.56
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 195.09 162.69 131.53 113.96 98.24 87.71
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 9.27 19.37 10.93 10.09 6.76 3.97
Earnings Per Share(Adj)-Unit Curr 9.27 9.48 5.35 4.94 3.31 1.94
Book Value 95.25 157.28 138.61 122.53 112.65 105.16
Book Value(Adj)-Unit Curr 95.25 76.96 67.82 59.95 55.12 51.46

Shareholding Pattern

  • Promoter Group

    63.77%

  • Public Share Holding

    36.23%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 13,258,684 37.92 13,258,684 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 9,037,662 25.85 9,037,662 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 22,296,346 63.77 22,296,346 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 200 0.00 200 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 40,910 0.12 40,910 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 41,110 0.12 41,110 4
2] Non Institution
Bodies Corporate 253,622 0.73 253,022 69
Clearing Members 22,433 0.06 22,433 13
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 413,824 1.18 413,824 207
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 545,361 1.56 545,361 386
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,255,932 12.17 4,255,932 38
Individuals holding nominal share capital up to Rs. 1 lakh 6,106,498 17.47 5,933,409 11,897
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 800,896 2.29 800,896 1
Sub Total 12,624,108 36.11 12,450,119 12,619
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 34,961,564 100.00 34,787,575 12,627

Company Background

Kilitch Drugs (India) LtdPharmaceuticals - Indian - Formulations

  • Kilitch Drugs (India) Ltd
  • BSE Code : 3630.0
  • ISIN : INE729D01010

  • Incorporation Year

    1992

  • Registered Office

    C-301/2 MIDC TTC Indl Area
    Pawane Village, Thane,
    Maharashtra-400705

  • Telephone

    91-022-27670322/27680913/65144185

  • FAX

    91-022-27680912

  • Chairman

    Mukund P Mehta

  • Managing Director

    Mukund P Mehta

  • Company Secretary

    Pushpa Nyoupane

  • Auditor

    C Sharat & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Kilitch Drugs (India) Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Kilitch Drugs 220.50 202.42 188.57 23.61 12.35
Abbott India 27,266.65 7,217.19 6,929.05 35.88 43.78
Astrazeneca Phar 6,254.35 2,304.07 2,275.58 92.18 27.86
Glaxosmi. Pharma 2,787.25 3,932.76 3,790.20 44.52 58.17
Novartis India 1,933.35 393.10 354.33 48.82 15.94
Cipla 1,383.00 20,102.60 18,979.95 36.35 13.88
Bliss GVS Pharma 710.05 773.53 729.81 65.99 12.51
Fermenta Biotec. 549.30 474.15 450.25 25.64 18.77
Amrutanjan Healt 506.15 520.13 502.55 27.11 24.16
Guj. Themis Bio. 404.40 168.25 165.82 108.13 18.05
Ambalal Sarabhai 39.24 19.52 3.94 72.67 6.77